Stroke (CVA) or TIA: Clinical Trials

2 trials for Stroke (CVA) or TIA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 31Unknown 1

Follow Stroke (CVA) or TIA: new trials by email Literature Review of Stroke (CVA) or TIA trials Research Report on Stroke (CVA) or TIA

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
[18F]AlF-OC - Stroke (CVA) or TIA, Carotid Artery Plaque
Phase 2RecruitingUniversitaire Ziekenhuizen KU Leuven242025-03-182025-08-11
Efficacy and Safety of Angong Niuhuang Wan for Stroke
Angong Niuhuang Wan, Angong Niuhuang Wan Placebo - Stroke (CVA) or TIA
Phase 2 / Phase 3UnknownChinese University of Hong Kong1002019-10-152021-01-29

Narrower conditions

Stroke (2)  ·  Atherosclerosis (1)  ·  Carotid Artery Diseases (1)  ·  Carotid Stenosis (1)  ·  Inflammation (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Vascular Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Bulk Drugs (1)

Sponsors

Chinese University of Hong Kong (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Belgium (1)  ·  Hong Kong (1)

Top investigators

Robin Lemmens, MD PhD (1)